本文以环丙沙星为代表，根据其在缓释和细胞内导向的新型载体形式研究情况，对其包合物及以包合物制成的药质体、纳米囊、脂质体等给药系统的制备工艺、性质、体内外抑菌试验等进行综述，分析和讨论新剂型对药动学及药效学性质影响的原因及药剂学机理。 In this paper, ciprofloxacin as the representative, according to its sustained-release and intracellular guidance of the new carrier form of research, its inclusion and inclusion complexes made of the drug body, nanocapsules, liposomes, etc. The preparation technology and properties of drug system, bacteriostasis test in vitro and in vivo were reviewed. The reason and pharmacology mechanism of new dosage form on pharmacokinetics and pharmacodynamic properties were analyzed and discussed.